SMI 8'990 0.1%  Dow 17'719 0.2%  Nikkei 17'172 -0.8%  Euro 1.2021 0.0%  BuySell
SPI 8'839 0.1%  EStoxx50 3'102 -0.7%  Gold 1'193 0.3%  Dollar 0.9579 0.0%  BuySell
DAX 9'484 0.1%  FTSE100 6'679 -0.3%  Öl 79.3 1.4%  Pfund 1.5036 0.0%  BuySell

Biomarin Pharmaceutical Aktie [Valor: 729021 / ISIN: US09061G1013]

Analysen zu Biomarin Pharmaceutical Inc.

24.10.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
06.11.12 Biomarin Pharmaceutical outperform RBC Capital Markets
03.09.12 Biomarin Pharmaceutical outperform RBC Capital Markets
28.08.12 Biomarin Pharmaceutical hold Deutsche Bank Securities
23.07.12 Biomarin Pharmaceutical outperform RBC Capital Markets
22.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
01.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
17.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
13.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
12.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
08.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
07.12.11 Biomarin Pharmaceutical buy Jefferies & Company Inc.
29.09.11 Biomarin Pharmaceutical buy Deutsche Bank Securities
25.10.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
17.08.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
16.04.10 Biomarin Pharmaceutical kaufen Der Aktionär
29.10.09 Biomarin Pharmaceutical outperform Credit Suisse Group
22.10.09 Biomarin Pharmaceutical buy Citigroup Corp.
19.10.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
08.10.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
03.08.09 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
31.07.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
27.07.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
31.03.09 Biomarin Pharmaceutical market weight Thomas Weisel Partners LLC
27.03.09 Biomarin Pharmaceutical neutral Piper Jaffray & Co.
12.03.09 Biomarin Pharmaceutical outperform Leerink Swann LLC
12.03.09 Biomarin Pharmaceutical buy FTN Midwest Securities Corp.
24.02.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
23.02.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
19.02.09 Biomarin Pharmaceutical neutral Credit Suisse Group
19.02.09 Biomarin Pharmaceutical market perform Wachovia Securities, LLC
19.02.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
19.02.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
09.01.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
15.12.08 Biomarin Pharmaceutical neutral Credit Suisse Group
26.11.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
24.11.08 Biomarin Pharmaceutical buy Citigroup Corp.
30.10.08 Biomarin Pharmaceutical neutral Credit Suisse Group
30.10.08 Biomarin Pharmaceutical buy UBS AG
29.10.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
12.09.08 Biomarin Pharmaceutical outperform William Blair
27.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
22.08.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
22.08.08 Biomarin Pharmaceutical market outperform Rodman & Renshaw, LLC
22.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
02.07.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
12.06.08 Biomarin Pharmaceutical hold Citigroup Corp.
29.05.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
28.02.08 Biomarin Pharmaceutical buy Merrill Lynch & Co., Inc.
28.02.08 Biomarin Pharmaceutical neutral UBS AG
Seite: 1 | 2

Anmeldung notwendig

Benutzername (E-Mail):
Passwort:
 
Anmelden
 

Um diese Funktionalität nutzen zu können, müssen Sie sich anmelden.
Falls Sie noch kein Benutzerkonto bei finanzen.ch besitzen, können Sie sich hier kostenlos registrieren.

Eintrag hinzufügen

Aktuelle Aktienanalysen
20.11.14 Michaels Stores Market Perform Telsey Advisory Group
20.11.14 Duke Energy Buy Argus Research Company
20.11.14 Dollar Tree Market Perform Telsey Advisory Group
20.11.14 TOTAL Hold S&P Capital IQ
20.11.14 Perry Ellis International Buy Wunderlich
20.11.14 Jacobs Engineering Group Mkt Perform FBR Capital
20.11.14 Salesforce Buy Deutsche Bank AG
20.11.14 JetBlue Airways Buy Deutsche Bank AG
20.11.14 Salesforce Buy Canaccord Adams
20.11.14 King Engine Bearings Hold Deutsche Bank AG
20.11.14 Cliffs Natural Resources Hold Deutsche Bank AG
20.11.14 Spectrum Brands Outperform Oppenheimer & Co. Inc.
20.11.14 L Brands Buy Wunderlich
20.11.14 Stein Mart Buy Canaccord Adams
20.11.14 Williams-Sonoma Neutral UBS AG
20.11.14 Lowes Companies Buy UBS AG
20.11.14 Target Neutral MKM Partners
20.11.14 JetBlue Airways Buy CRT Capital
20.11.14 BHP Billiton Neutral JP Morgan Chase & Co.
20.11.14 UniCredit Hold Kepler Cheuvreux
20.11.14 Hugo Boss Hold Kepler Cheuvreux
20.11.14 ASML overweight JP Morgan Chase & Co.
20.11.14 KUKA buy Citigroup Corp.
20.11.14 Banco Bilbao Vizcaya Argentaria Neutral Citigroup Corp.
20.11.14 ThyssenKrupp Hold S&P Capital IQ
20.11.14 Targa Resources Partners LPPartnership Units Buy Global Hunter Securities
20.11.14 Bilfinger Hold Kepler Cheuvreux
20.11.14 Hugo Boss Neutral JP Morgan Chase & Co.
20.11.14 Banco Bilbao Vizcaya Argentaria buy UBS AG
20.11.14 Wirecard buy Kepler Cheuvreux
20.11.14 Salzgitter buy UBS AG
20.11.14 DIC ASSET buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
20.11.14 Tribune Publishing Hold Gabelli & Co
20.11.14 ThyssenKrupp kaufen Independent Research GmbH
20.11.14 Hugo Boss Hold Hauck & Aufhäuser Privatbankiers KGaA
20.11.14 ThyssenKrupp Reduce Kepler Cheuvreux
20.11.14 KUKA Verkaufen Norddeutsche Landesbank (Nord/LB)
20.11.14 Wirecard Conviction Buy List Goldman Sachs Group Inc.
20.11.14 Zalando Sell Warburg Research
20.11.14 Siemens Conviction Buy List Goldman Sachs Group Inc.
20.11.14 Merck kaufen DZ-Bank AG
20.11.14 HeidelbergCement Underperform Credit Suisse Group
20.11.14 Regeneron Pharmaceuticals Buy Brean Capital
20.11.14 Münchener Rückversicherungs-Gesellschaft Underperform Credit Suisse Group
20.11.14 KWS SAAT Hold Warburg Research
20.11.14 Palo Alto Networks Outperform Oppenheimer & Co. Inc.
20.11.14 CTS EVENTIM Hold Warburg Research
20.11.14 Bob Evans Farms Outperform Oppenheimer & Co. Inc.
20.11.14 Hannover Rueck kaufen Credit Suisse Group
20.11.14 Galena Biopharma Buy MLV Capital